Navigation Links
FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
Date:11/30/2007

ine is not fully known, scientists believe its effects on depression and anxiety symptoms, as well as its effect on pain perception, may be due to increasing the activity of serotonin and norepinephrine in the central nervous system.

Important Safety Information

Cymbalta is approved to treat major depressive disorder and generalized anxiety disorder and manage diabetic peripheral neuropathic pain. Antidepressants can increase suicidal thoughts and behaviors in children, adolescents and young adults. Patients should call their doctor right away if they experience new or worsening depression symptoms, unusual changes in behavior, or thoughts of suicide. Be especially observant within the first few months of treatment or after a change in dose. Cymbalta is approved only for adults 18 and over.

Cymbalta is not for everyone. Patients should not take Cymbalta if they have recently taken a type of antidepressant called a monoamine oxidase inhibitor (MAOI), are taking Mellaril(R) (thioridazine) or have uncontrolled glaucoma. Patients should speak with their doctor about any medical conditions they may have, including liver or kidney problems or glaucoma. Patients should tell their doctor about all of their medicines, including those for migraine to avoid a potentially life-threatening condition, and NSAIDs, aspirin or blood thinners due to an increased risk of bleeding. They also should talk to their doctor about their alcohol consumption. Patients should consult with their doctor before stopping Cymbalta or changing the dose and if they are pregnant or nursing.

Patients taking Cymbalta may experience dizziness or fainting upon standing. The most common side effects of Cymbalta include nausea, dry mouth, sleepiness and constipation. This is not a complete list of side effects.

For full Patient Information, visit http://www.cymbalta.com.

For full Prescribing Information, including B
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
4. Abbotts ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study
5. SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
6. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
9. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
10. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
11. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., PHILADELPHIA,Nov.25/PRNewswire-FirstCall/--ERT...lvey,theCompany,sPresidentandCEO,andKeithSchneck,t...edtopresentatthe21stAnnualPiperJaffrayHealthCareCo...ewYork. ,, Interestedpartiesmayaccessthepresent...://www.ert.com .Thewebcastmayalsobeaccessedat http...
(Date:11/25/2009)..., CHICAGOandSTAFA,Switzerland,Nov.25/PRNewswire/...ofinnovativehearingsolutions,presentedthesecondedi...thespecialneedsoftheolderpopulation.Theconferenceb...maroundtheworldandmorethan250clinicianswhoworkever...toshareexperiencesanddiscussthelatestresearchandtr...
(Date:11/25/2009)..., EXTON,Pa.,Nov.25/PRNewswire/--BioTrendsResearc... Stelara report,thefirstinamulti-phasesyndicated...tho-Biotech,sStelara,fromproductlaunchthroughthefi...idesquantitativeinformationfrom75uniqueDermatologi...ortsassesstrialanduseofStelara,obstaclestouse,typi...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2FDA Consumer Health Information Updates 3A New Web Videos Educate Consumers About Food and Medical Product Safety 58600 1FDA Consumer Health Information Updates 3A New Web Videos Educate Consumers About Food and Medical Product Safety 58600 2MOAA Decries 21 25 TRICARE Inpatient Copay Hike 58596 1MOAA Decries 21 25 TRICARE Inpatient Copay Hike 58596 2Commercial Insurance Buyers Benefit From Ample Capacity 14306 1Commercial Insurance Buyers Benefit From Ample Capacity 14306 2Commercial Insurance Buyers Benefit From Ample Capacity 14306 3
... concept in topical models of,infection , REINACH ...SWX: ARPN) today announced positive results of in ... a large panel of,clinical isolates, including tho...tion, topical applications of AR-2474 were found,t...esistant,Staphylococcus aureus (MRSA) in preclinic...
...arch UK scientists in Glasgow,have devised a new m...indings in the Journal of Clinical Investigation* ...Beatson Institute for Cancer,Research gave mice a ...e, significantly slowing the growth of the tumours...ene called p73 that brings,about cancer cell death...
Other Medicine Technology:Arpida adds novel antibiotic AR-2474 to its preclinical pipeline 2Arpida adds novel antibiotic AR-2474 to its preclinical pipeline 3Scottish Scientists Test ‘Secret Weapon’ Against,Tumours 2Scottish Scientists Test ‘Secret Weapon’ Against,Tumours 3
(Date:11/25/2009)...incare ®isproudtosupportGNC,seffortstoraisemo...de ThanksandGiving campaign,$1fromthepurchaseprice... willbedonatedtoSt.Jude.Additionally,GNCcustomersh...utatoneoftheir5,000+retaillocationsoratGNC.com.GNC...2009 ThanksandGiving campaign. ,, "Wearedelight...
(Date:11/25/2009)...wire/--TheAmericanAssociationforHomecareendorsesth...isdesignedtosubstantiallyimprovetoolsandresourcesa...cedbySen.GeorgeLeMieux(R-Fla.). ,, TheLeMieuxbi...orHomecareoutlinedinits13-pointanti-fraudactionpla...Thoseprovisionsincludecallingforreal-timeauditsand...
(Date:11/25/2009)...ghtYear ,, WASHINGTON,Nov.25/PRNewswire-USNew...issuedthe 4thAnnualReportCardonLungCancer .ThisRep...haldiseaseinthestateofGeorgia.LCA-GAisachapterofLu...edicatedexclusivelytopatientsupportandadvocacyforp... http://www.newscom.com/cgi-bin/prnh/20081016/LCAL...
(Date:11/25/2009)... into the body on a carefully engineered, fingerna...inate tumors in mammals, scientists report this we.... , The new approach, pioneered by bioengineers ...tic disks impregnated with tumor-specific antigens...malian immune system to attack tumors. The new pap...
(Date:11/25/2009)...can reverse a rare stomach disorder and should be ...earchers at Vanderbilt University Medical Center r...ening of the stomach lining, severe abdominal pain...ing in the feet and ankles due to protein loss. Pa...reviously, the only effective treatment was gastre...
Breaking Medicine News(10 mins):Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2
...al Agency for Cancer Research scientists (IACR) ha...educes the incidence of lung cancer. The study ...nd 2,168 healthy individuals from Poland, Slovakia...uced the incidence of lung cancer in people who ha...
...ika Sanctuary in Orissa is very high as migratory ...n an other 2-3 weeks. Bhitarkanika Sanctuary is ab...ly 300,000 migratory birds arrive from all parts o...ds are regularly sighted. The Sanctuary is also kn...
... P. in its specialty hospital has a Telemedicine p...y a Bangalore based company called Televital. Now ... Railway Hospital at Raipur and Nagpur. The Teleme...that runs parallel railways track. Almost the whol...
...ical School have identified a possible cause of pr...tter forms of treatment or possibly a cure. The st...zine. The findings show a recurring pattern of...lity in the majority of prostate cancer tissue sam...
...tponement of childbearing, and a small number of c...embryonic and fetal loss often cause disappointmen...ucted in women to address the issue of whether abo...veal that pre-existing mental health might be a be...
... established in the womb and early childhood can p...age. Researchers have linked a birth weight und... age 2, and a BMI above 17.5 at age 11 with a sign...s those whose BMIs fell from over 17 at age 2 to u...
Other Medicine News:Health News:Cabbage And Genes May Protect Against Lung Cancer 2Health News:Bhitarkanika Sanctuary In Orissa Takes Precaution To Monitor Bird Flu 2Health News:Abortion Does Not Increase Risk Of Depression In Women 2Health News:Early Growth Patterns Can Predict Heart Disease 2
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: